1. Home
  2. NICE vs APGE Comparison

NICE vs APGE Comparison

Compare NICE & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NICE Ltd

NICE

NICE Ltd

HOLD

Current Price

$101.79

Market Cap

5.6B

Sector

Technology

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$134.66

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NICE
APGE
Founded
1986
2022
Country
Israel
United States
Employees
9626
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
4.7B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
NICE
APGE
Price
$101.79
$134.66
Analyst Decision
Buy
Strong Buy
Analyst Count
13
13
Target Price
$153.46
$109.67
AVG Volume (30 Days)
622.2K
1.1M
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.14
N/A
Revenue Next Year
$9.62
N/A
P/E Ratio
$11.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$83.10
$35.39
52 Week High
$153.62
$134.88

Technical Indicators

Market Signals
Indicator
NICE
APGE
Relative Strength Index (RSI) 55.76 78.81
Support Level $96.49 $134.03
Resistance Level $106.36 N/A
Average True Range (ATR) 4.39 0.26
MACD 0.23 -1.20
Stochastic Oscillator 80.36 72.67

Price Performance

Historical Comparison
NICE
APGE

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: